Articles On Telix Pharmaceuticals (ASX:TLX)

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 /PRNewswire/ — Telix Pharma...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets moved higher, tickling near all time high levels despite a downward revis...

Highlights Artrya (ASX:AYA) expands with major funding for heart disease detection devices Telix Pharmaceuticals (ASX:TLX) advances brain cancer imaging with FDA alignment Argenica Therapeutics (ASX:AGN) gains traction with...

Highlights Short interest themes reshape focus across banks, miners, retail, and healthcare Coverage trends diverge as catalysts hit balance sheets and project pipelines Market tone split between cyclical caution and themati...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is racing higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $13.60. In earlier trade shares were up mo...

Highlights Short-selling trends mapped to miners, banks, retail, healthcare, tech, and real estate Brief, entity-rich snapshots for each company referenced with one clean ticker mention Neutral tone focused on activity, sect...

Highlights Short sellers increase activity across multiple S&P/ASX 200 companies, spanning travel, food, healthcare, and resources. Companies such as Flight Centre (ASX:FLT), Domino’s Pizza (ASX:DMP), and Guzman y Gomez (ASX:...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Despite at times a bruising August reporting season, the index topped new all time h...

The FDA has requested more data from a slew of ASX drug developers requesting marketing approval, or permission to undertake a trial Telix has received two FDA ‘complete response’ letters, but the company says investors should not be conce...

With earnings season over, investors may be reflecting on last month's results and significant share price moves. This exercise can provide insight into which companies and sectors have momentum behind them. It can also identify compani...

Highlights Companies like Telix (ASX:TLX), Austal (ASX:ASB), Pro Medicus (ASX:PME), and Cochlear (ASX:COH) continue to strengthen their US footprint. CSL (ASX:CSL), Reece (ASX:REH), Unibail-Rodamco-Westfield (ASX:URW), and Guzman...

Highlights IPH and Monash IVF Group experience sharp increases in short interest following earnings updates Reliance Worldwide and Inghams see rising shorts amid weaker performance and outlooks Clinuvel and Novonix lead the...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

If you are hunting for big returns for your investment portfolio, then look no further than the ASX 200 shares in this article. That's because analysts are tipping them to rise by 25%+ over the next 12 months. Here's what you need to know a...

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these...

The government has just handed first home buyers what looks like a golden ticket, but it could be the fuse for a ticking time bomb. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from t...

ASX rises 0.22pc after flat day of trade Earnings reports from big cap companies weighed heavy Gains and losses equalised after lunch for steady end to day ASX edges higher on earnings equilibrium It was another tale of heroes and villai...

The ASX200 traded flat today leading into close. Real Estate was the best performing sector, followed by Financials and Industrials. Energy was by far the worst performing sector, followed by Health Care and IT. In the Green Qa...

In late trade on Thursday, the S&P/ASX 200 Index (ASX: XJO) is on track to record a small gain. At the time of writing, the benchmark index is up 0.1% to 8,972.1 points. Four ASX shares that have failed to follow the market higher today...

Highlights Australian shares hovered near flat as gains in financials offset losses in healthcare Qantas and IDP Education stood out with strong market interest amid corporate updates Telix Pharmaceuticals and Ramsay Health...

With more than seven million users on the HotCopper forums, every discussion and speculation can move Australian markets – which is why getting out in front of those trends is so important for any trader worth their salt. Listen to the H...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are getting pounded today. Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $18.40. In earlier trade, shares crashed to $13....

The FDA has refused Telix’s kidney imaging marketing application, sending shares into a $1.1 billion plus tailspin With Somnomed firing, investors (and patients) are sleeping easier Alcidion is back in black on UK hospital demand   Radiop...

Telix (ASX:TLX) has experienced a jolt in its recovery following its July 22 quarterly that saw prices sink – now, the FDA has knocked back an investigational PET scan agent Telix submitted, lengthening out that product’s path to sales. Per...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin FNArena's Monitor keeps track of corporate earnings result releases, including broke...

  Highlights ASX 200 and All Ordinaries surged to new highs with strength across all sectors Industrials, Consumer Staples, and Consumer Discretionary led gains with strong moves from key stocks Battery metals and rare eart...

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these...

Telix Pharmaceuticals Ltd (ASX: TLX) shares were on form on Thursday. The ASX 200 biotech stock raced 7% higher to end the session at $18.10. This was driven by the release of its half year results for FY 2025. Where next for Telix shares?...

ASX smashes records to close at intraday high of 9019 points Market shows impressive strength, with every sector and index moving higher Industrials sector a powerhouse of momentum   It’s over 9000!! The ASX is well and truly showing its...

It was a watershed day for the S&P/ASX 200 Index (ASX: XJO) this Thursday. Today marked the first time in history that the ASX 200 ascended past the 9,000-point mark, once again resetting its record...

The ASX 200 has smashed through the big 9,000 mark for the first time ever, hitting a fresh all-time high of 9,013 in intraday trade. Yep, we’ve finally cracked it! Industrials led the charge in sectors, giving the market a solid boost,...

  Highlights Objective Corporation (ASX:OCL), Super Retail Group (ASX:SUL), and Codan (ASX:CDA) led early gains on the index Brambles (ASX:BXB) advanced with strong results and capital return updates Megaport (ASX:MP1) and...

  Highlights Banks including (ASX:ANZ), (ASX:NAB) and (ASX:WBC) remained firm within the asx 200 Real estate majors such as (ASX:CHC), (ASX:SCG) and (ASX:SGP) advanced across sessions Uptrend and downtrend scans reflected c...

Highlights US markets ease ahead of Jackson Hole meeting Defensive sectors support local benchmark Busy earnings calendar for ASX companies The ASX 200 stocks are expected to open on a positive note as global cues continue to shap...

  Highlights Evolution Mining (ASX:EVN) noted for exposure to both gold and copper markets Telix Pharmaceuticals (ASX:TLX) recognised for advancements in radiopharmaceutical development Both companies are listed on the ASX...

Radiopharm Theranostics (ASX:RAD) pales in size relative to ASX peer Telix Pharmaceuticals and US nuclear medicine titan Lantheus, but CEO Riccardo Canevari is happy to walk in the shadow of giants. Canevari notes the duo’s pioneering role...

Highlights ASX set to ease after strong record run Global cues shape investor sentiment Corporate earnings remain in spotlight The ASX is expected to take a breather after a stretch of record highs, with futures pointing to a soft...

ASX closes out week-long rally on new record high of 8938 points Market set a new intraday high every day this week Broad sector strength, led by financials and materials   From strength to strength The ASX’s trade performance this week h...

There’s nothing like a great biotech rivalry, such as the one between radio-pharmaceutical peers Clarity Pharmaceuticals (ASX:CU6) and Telix Pharmaceuticals (ASX:TLX). Raising the stakes, Clarity executive chairman Dr Alan Taylor makes a ba...

Despite myriad pressures under the Trump regime, the FDA’s drug and device approval process largely has been unfettered Telix Pharmaceuticals expects a company-making approval decision by the end of the month Painchek is among a string of...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

Every week, hundreds of companies go through the ups and downs of the ASX rollercoaster, with fortunes made and equity lost each time the bourse opens – which is why keeping an eye on the hot stocks is so key. Listen to the HotCopper pod...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin This week's In Brief has a selection of growing winners with upside potential and st...

  Highlights Rebalance across S&P/ASX indices to reshape index composition Passive investment strategies drive significant stock movements Stocks with strong momentum may attract increased fund flows asx today 200...

Many of Australia's top brokers have been busy adjusting their financial models and recommendations again. This has led to the release of a number of broker notes this week. Three ASX shares that brokers have named as buys this week are lis...

  Highlights Market sentiment lifted by expectations of softer monetary policy across global economies Key sectors including consumer discretionary and financials contributed to the upswing Prominent gains noted among diver...

Nanosonics has hit the double jackpot with its second FDA approval for the year Investor fatigue? Amplia shares tumble after further encouraging pancreatic cancer trial data Duelling parties in the Mayne Group (non) takeover offer stick...

With multiple clinical trials and approval applications in train, nuclear medicine superstar Telix Pharmaceuticals (ASX:TLX) is like one of those irritatingly brilliant all-round students. We’re thinking of the straight-A school captain who...

The ASX200 was trading higher approaching close after a day of buoyant investor sentiment. Discretionary, Real Estate and IT sectors lead the bourse into positive territory on a day when all sectors were solidly in the green. In the G...